Plato Investment Management Ltd Acquires Shares of 17,251 Danaher Corporation $DHR

Plato Investment Management Ltd acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 17,251 shares of the conglomerate’s stock, valued at approximately $3,267,000.

Other hedge funds also recently made changes to their positions in the company. Main Street Group LTD purchased a new stake in Danaher in the 1st quarter valued at approximately $25,000. N.E.W. Advisory Services LLC acquired a new stake in Danaher in the 2nd quarter valued at about $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth $26,000. Finally, WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter valued at about $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. HSBC decreased their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Royal Bank Of Canada raised their target price on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Wells Fargo & Company dropped their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Stock Performance

NYSE:DHR opened at $202.51 on Monday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market cap of $142.37 billion, a PE ratio of 35.97, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The firm’s fifty day simple moving average is $193.14 and its 200-day simple moving average is $192.91. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.77 earnings per share. Analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.